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A GENETIC POLYMORPHISM has been
described of the human Group I pepsino-
gens (Samloff, 1969) characterized by the
presence or absence ofpepsinogen 5, called
phenotypes A and B respectively (Samloff
& Townes, 1970a). The inheritance ofthese
phenotypes is controlled by 2 genes at an
autosomal locus, phenotype B being in-
herited as an autosomal recessive trait
(Samloff & Townes, 1970b). In an Ameri-
can Caucasian population, 84.4% were
phenotype A and 15.5% were phenotype B
(Samloff & Townes, 1970a). In contrast,
100% of a group of 229 Japanese individ-
uals were phenotype A and no phenotype
B persons were detected (Samloff et al.,
1973). Of interest is the fact that the
Japanese also have the highest incidence
of carcinoma of the stomach in the world
(Segi, 1978). It was decided therefore to
compare the distribution of pepsinogen
phenotypes in a group of patients with
gastric neoplasms and controls.
The patients were seen on the Gastro-
enterlogy Units and wards of the Royal
Liverpool and Broadgreen Hospitals,
Liverpool. Most were ascertained at endo-
scopy; the rest were seen after laparotomy
for apositive radiological finding.
In 46/50 there was histological proofofa
gastric malignancy. In 3 cases the radio-
logist and endoscopist were convinced of
the malignant nature of the lesion but the
histology of the endoscopic biopsy mater-
ial was not confirmatory, and the patients
refused operation. In one case an extensive
gastric neoplasm with hepatic metastases
was found at laparotomy and the patient's
abdomen was closed without a biopsy
being carried out. Of the 46 histologically
proven neoplasms, 43 were adenocarcino-
mas of varying degrees of differentiation
and 3 were lymphomas. The adenocarcino-
mas consisted of 24 men and 19 women.
The age range ofthe men was 40-79 with a
mean of 65 years, and women's ages
ranged from 19 to 87 with a mean of 70
years. Most of the control urine samples
were obtained from workers at Plessey
Communications Ltd, Edge Lane, Liver-
pool, and the rest from nursing and
university staff born in Merseyside.
A random sample ofurine was obtained
from each patient. After adding sodium
azide, the urine was concentrated 20 times
using Amicon B-15 miniconcentrators
(Amicon Ltd, Woking, England). The
concentrated samples were stored at 4TC
until tested.
Pepsinogen phenotypes were determin-
ed by agar-gel electrophoresis, according
to the method of Samloff (Samloff, 1969).
Electrophoresis was carried out on glass
plates 200 x 200 x 1 mm in 1.5% Difco
Noble agar gel in 00CM barbital buffer
(pH 8.3) at 11 V/cm for 3j.h in a TLC
Mk II electrophoresis chamber (Shandon
Southern Products Ltd, England) which
was cooled by circulating iced water. The
samples were mixed with an equal volume
of warm 3% agar and pipetted into slots
(1 x 10 mm) at the cathodal side of the
plate. After the run the plate was
immersed in acid-haemoglobin for 15 min,
incubated in a humid atmosphere for 1 h
at 370C, fixed in acid-alcohol overnight
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TABLE I.-Pepsinogen phenotypes and
gastric neoplasms
Phenotype
A B Total
Adenocarcinomas 42 1 43
Lymphomas 3 0 3
Histology negative
gastric neoplasms 4 0 4
Controls 436 74 510
and stained with amido black. The pep-
sinogens appeared as white bands on a
black background.
Of the 43 histologically proved adeno-
carcinoma group there were 42 (97.7%)
phenotype A patients and 1 (2.3%)
phenotype B patient which is significantly
different at the 5% level (X2 = 5-02,
P < 0.05) from the control group compris-
ing 436 (85.4%) phenotype A and 74
(14.6%) phenotype B individuals (Table
I). If the 3 lymphomas are included with
the adenocarcinomas then the results are
even more significant (x2 = 5-7, P < 0-02)
(Table I), there being 45 phenotype A but
still only 1 phenotype B patient. The
relative risk (Woolf) is 7-8, indicating that
a phenotype A individual has nearly 8
times the risk of developing a gastric
malignancy as a phenotype B individual.
If the 4 unconfirmed but strongly suspec-
ted cases of gastric malignancy are also
included the results are even more signifi-
cant as they too were all phenotype A,
making 49 (98%) phenotype A compared
to 1 (2%) phenotype B (X2 = 6 14,P < 0 02).
Table II gives the distribution of the
ABO blood groups of the 29 patients in
whom the blood group was known.
The results demonstrate a significant
association between the pepsinogen pheno-
types and carcinoma ofthe stomach. Ifthis
TABLE IL.-Distribution of ABO blood
groups in patients with gastric neoplasms
Blood number Number %
0 14 50
A 11 36
B 3 11
AB 1 3
29
association is confirmed, one has to
consider the reason forsuch an association.
One possibility is that a gastric malig-
nancy susceptibility gene is in linkage
disequilibrium with the pga allele at the
pepsinogen locus. Alternatively, pepsino-
gen 5 could inter-react with an environ-
mental factor and convert it to a gastric
carcinogen or phenotype B could protect
against such an agent. A possible but very
unlikely explanation could be that the
neoplastic tissue produces a proteolytic
enzyme, a cathepsin which migrates on the
electrophoretic plate to the same extent as
pepsinogen 5, thus converting some pheno-
type B patterns into apparent phenotype
A patterns. Further investigation of the
association may throw some light on the
pathogenesis of gastric carcinoma.
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